William J Link Phd insider trades

Open-market stock purchases and sales by William J Link Phd, Director at Tarsus Pharmaceuticals, Inc, from SEC Form 4 filings since May 14, 2010.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -67%.

Recent trades

DateStockTradeValue
Sep 15, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Sep 15, 2026TARS Tarsus Pharmaceuticals, IncSold$915K
Sep 15, 2026TARS Tarsus Pharmaceuticals, IncSold$60K
Sep 15, 2026TARS Tarsus Pharmaceuticals, IncSold$5.3K
Jun 25, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Jun 25, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Jun 25, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Jun 17, 2026RXST RxSight, IncBought (not open market)—
Jun 15, 2026TARS Tarsus Pharmaceuticals, IncSold$655K
Jun 15, 2026TARS Tarsus Pharmaceuticals, IncSold$121K
Jun 12, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Jun 3, 2026LNSR LENSAR, IncBought (not open market)—
Mar 16, 2026TARS Tarsus Pharmaceuticals, IncSold$34.4K
Mar 16, 2026TARS Tarsus Pharmaceuticals, IncSold$247K
Mar 16, 2026TARS Tarsus Pharmaceuticals, IncSold$578K
Dec 15, 2025TARS Tarsus Pharmaceuticals, IncSold$94.6K
Dec 15, 2025TARS Tarsus Pharmaceuticals, IncSold$458K
Dec 15, 2025TARS Tarsus Pharmaceuticals, IncSold$388K
Dec 15, 2025TARS Tarsus Pharmaceuticals, IncSold$408K
Dec 15, 2025TARS Tarsus Pharmaceuticals, IncSold$516K

Companies traded

  • TARS Tarsus Pharmaceuticals, Inc: 16 sales, last Sep 15, 2026
  • RXST RxSight, Inc: 1 buy, 2 sales, last Jun 17, 2026
  • LNSR LENSAR, Inc: other filings, last Jun 3, 2026
  • OYST Oyster Point Pharma, Inc: 1 buy, 4 sales, last Jan 5, 2022
  • GKOS GLAUKOS Corp: 8 sales, last Jun 3, 2021
  • EW Edwards Lifesciences Corp: 8 sales, last May 8, 2020
  • EYES Second Sight Medical Products Inc: other filings, last Jun 4, 2019
  • INGN Inogen Inc: other filings, last Feb 20, 2014

Get free alerts when William J Link Phd files a new trade →